US Stock MarketDetailed Quotes

TCON Tracon Pharmaceuticals

Watchlist
  • 1.2800
  • +0.0300+2.40%
Close May 31 16:00 ET
  • 1.3200
  • +0.0400+3.13%
Post 17:34 ET
3.43MMarket Cap0.40P/E (TTM)

Tracon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
49.17%-2.54M
114.01%3.68M
88.78%-522K
320.48%15.05M
27.02%-5.85M
25.79%-5M
-16.25%-26.24M
9.01%-4.65M
18.96%-6.83M
-92.07%-8.02M
Net income from continuing operations
62.75%-3.17M
87.68%-3.59M
106.27%439K
267.26%10.76M
-0.90%-6.29M
10.23%-8.5M
-1.63%-29.14M
9.27%-7M
7.44%-6.44M
30.31%-6.23M
Depreciation and amortization
-27.27%8K
-51.43%34K
-36.36%7K
-87.10%8K
-66.67%8K
140.74%11K
218.64%70K
139.29%11K
444.44%62K
442.86%24K
Other non cash items
----
852.83%7.41M
--0
2,808.70%669K
276,550.00%5.53M
17,200.00%1.21M
574.39%778K
6,116.67%746K
27.78%23K
100.90%2K
Change In working capital
-86.96%234K
-800.42%-2.15M
-268.75%-1.46M
425.57%3.12M
-138.84%-5.61M
-18.52%1.8M
-105.26%-239K
-58.86%864K
51.44%-958K
-151.30%-2.35M
-Change in prepaid assets
-94.36%15K
289.86%269K
-86.75%51K
46.85%-321K
254.55%273K
26.07%266K
186.25%69K
2.12%385K
12.34%-604K
-70.04%77K
-Change in payables and accrued expense
-85.68%219K
-686.04%-2.42M
-415.03%-1.51M
-1,470.62%-5.56M
228.62%3.12M
-23.24%1.53M
-106.66%-308K
-72.20%479K
72.43%-354K
-156.13%-2.43M
Cash from discontinued investing activities
Operating cash flow
49.17%-2.54M
114.01%3.68M
88.78%-522K
320.48%15.05M
27.02%-5.85M
25.79%-5M
-16.25%-26.24M
9.01%-4.65M
18.96%-6.83M
-92.07%-8.02M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-100.43%-17K
55.56%-4K
22.22%-7K
-100.05%-2K
Net PPE purchase and sale
----
--0
--0
--0
----
----
64.58%-17K
55.56%-4K
22.22%-7K
92.31%-2K
Net investment purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
--0
--0
--0
----
----
-100.43%-17K
55.56%-4K
22.22%-7K
-100.05%-2K
Financing cash flow
Cash flow from continuing financing activities
132.13%1.87M
-163.70%-12.54M
-73.23%1.32M
-186.86%-9.09M
-78.87%1.05M
-748.40%-5.82M
86.40%19.68M
800.42%4.95M
-17.94%10.47M
889.65%4.96M
Net issuance payments of debt
--0
-275.06%-20.5M
--0
-205.42%-10.5M
--0
-1,328.57%-10M
518.21%11.71M
590.00%3.43M
1,522.86%9.96M
-40.00%-980K
Net common stock issuance
-55.26%1.87M
0.47%7.92M
-10.01%1.32M
178.46%1.41M
-82.94%1.01M
29,757.14%4.18M
-40.36%7.88M
2,820.37%1.47M
-96.24%506K
73,725.00%5.89M
Proceeds from stock option exercised by employees
----
-52.63%45K
-95.65%2K
--0
----
----
-36.24%95K
-4.17%46K
--0
----
Cash from discontinued financing activities
Financing cash flow
132.13%1.87M
-163.70%-12.54M
-73.23%1.32M
-186.86%-9.09M
-78.87%1.05M
-748.40%-5.82M
86.40%19.68M
800.42%4.95M
-17.94%10.47M
889.65%4.96M
Net cash flow
Beginning cash position
-50.65%8.64M
-27.30%17.5M
-54.48%7.84M
-86.20%1.87M
-59.87%6.68M
-27.30%17.5M
-25.08%24.07M
-42.44%17.21M
-46.91%13.58M
-36.99%16.64M
Current changes in cash
93.78%-673K
-34.86%-8.86M
178.47%802K
64.12%5.96M
-56.96%-4.8M
-45.63%-10.82M
18.45%-6.57M
104.94%288K
-15.95%3.63M
-269.57%-3.06M
End cash Position
19.28%7.96M
-50.65%8.64M
-50.65%8.64M
-54.48%7.84M
-86.20%1.87M
-59.87%6.68M
-27.30%17.5M
-27.30%17.5M
-42.44%17.21M
-46.91%13.58M
Free cash flow
49.17%-2.54M
114.00%3.68M
88.79%-522K
320.25%15.05M
27.04%-5.85M
25.84%-5M
-16.08%-26.26M
9.10%-4.66M
18.96%-6.83M
-90.93%-8.02M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 49.17%-2.54M114.01%3.68M88.78%-522K320.48%15.05M27.02%-5.85M25.79%-5M-16.25%-26.24M9.01%-4.65M18.96%-6.83M-92.07%-8.02M
Net income from continuing operations 62.75%-3.17M87.68%-3.59M106.27%439K267.26%10.76M-0.90%-6.29M10.23%-8.5M-1.63%-29.14M9.27%-7M7.44%-6.44M30.31%-6.23M
Depreciation and amortization -27.27%8K-51.43%34K-36.36%7K-87.10%8K-66.67%8K140.74%11K218.64%70K139.29%11K444.44%62K442.86%24K
Other non cash items ----852.83%7.41M--02,808.70%669K276,550.00%5.53M17,200.00%1.21M574.39%778K6,116.67%746K27.78%23K100.90%2K
Change In working capital -86.96%234K-800.42%-2.15M-268.75%-1.46M425.57%3.12M-138.84%-5.61M-18.52%1.8M-105.26%-239K-58.86%864K51.44%-958K-151.30%-2.35M
-Change in prepaid assets -94.36%15K289.86%269K-86.75%51K46.85%-321K254.55%273K26.07%266K186.25%69K2.12%385K12.34%-604K-70.04%77K
-Change in payables and accrued expense -85.68%219K-686.04%-2.42M-415.03%-1.51M-1,470.62%-5.56M228.62%3.12M-23.24%1.53M-106.66%-308K-72.20%479K72.43%-354K-156.13%-2.43M
Cash from discontinued investing activities
Operating cash flow 49.17%-2.54M114.01%3.68M88.78%-522K320.48%15.05M27.02%-5.85M25.79%-5M-16.25%-26.24M9.01%-4.65M18.96%-6.83M-92.07%-8.02M
Investing cash flow
Cash flow from continuing investing activities 000-100.43%-17K55.56%-4K22.22%-7K-100.05%-2K
Net PPE purchase and sale ------0--0--0--------64.58%-17K55.56%-4K22.22%-7K92.31%-2K
Net investment purchase and sale ------0------------------0------------
Cash from discontinued investing activities
Investing cash flow ------0--0--0---------100.43%-17K55.56%-4K22.22%-7K-100.05%-2K
Financing cash flow
Cash flow from continuing financing activities 132.13%1.87M-163.70%-12.54M-73.23%1.32M-186.86%-9.09M-78.87%1.05M-748.40%-5.82M86.40%19.68M800.42%4.95M-17.94%10.47M889.65%4.96M
Net issuance payments of debt --0-275.06%-20.5M--0-205.42%-10.5M--0-1,328.57%-10M518.21%11.71M590.00%3.43M1,522.86%9.96M-40.00%-980K
Net common stock issuance -55.26%1.87M0.47%7.92M-10.01%1.32M178.46%1.41M-82.94%1.01M29,757.14%4.18M-40.36%7.88M2,820.37%1.47M-96.24%506K73,725.00%5.89M
Proceeds from stock option exercised by employees -----52.63%45K-95.65%2K--0---------36.24%95K-4.17%46K--0----
Cash from discontinued financing activities
Financing cash flow 132.13%1.87M-163.70%-12.54M-73.23%1.32M-186.86%-9.09M-78.87%1.05M-748.40%-5.82M86.40%19.68M800.42%4.95M-17.94%10.47M889.65%4.96M
Net cash flow
Beginning cash position -50.65%8.64M-27.30%17.5M-54.48%7.84M-86.20%1.87M-59.87%6.68M-27.30%17.5M-25.08%24.07M-42.44%17.21M-46.91%13.58M-36.99%16.64M
Current changes in cash 93.78%-673K-34.86%-8.86M178.47%802K64.12%5.96M-56.96%-4.8M-45.63%-10.82M18.45%-6.57M104.94%288K-15.95%3.63M-269.57%-3.06M
End cash Position 19.28%7.96M-50.65%8.64M-50.65%8.64M-54.48%7.84M-86.20%1.87M-59.87%6.68M-27.30%17.5M-27.30%17.5M-42.44%17.21M-46.91%13.58M
Free cash flow 49.17%-2.54M114.00%3.68M88.79%-522K320.25%15.05M27.04%-5.85M25.84%-5M-16.08%-26.26M9.10%-4.66M18.96%-6.83M-90.93%-8.02M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg